SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001062993-19-003631
Filing Date
2019-09-06
Accepted
2019-09-06 15:41:15
Documents
1
Period of Report
2019-09-03

Document Format Files

Seq Description Document Type Size
1 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES form4.html 4  
1 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES form4.xml 4 5052
  Complete submission text file 0001062993-19-003631.txt   6393
Mailing Address 35 WILBUR STREET LYNBROOK NY 11563
Business Address 35 WILBUR ST LYNBROOK NY 11563 5165937000
BIOSPECIFICS TECHNOLOGIES CORP (Issuer) CIK: 0000875622 (see all company filings)

IRS No.: 113054851 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 191 MEADOWVIEW AVENUE HEWLETT NY 11557
Business Address
Schamroth Michael (Reporting) CIK: 0001375385 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-34236 | Film No.: 191079592